Purpose
to enable the optimization of anti-SARS-CoV-2 mAb candidates for developability and lowest cost of goods to produce a mAb product for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries
Grantee
Division
Global Health
Date
SEPTEMBER 2020
Region served
GLOBAL
Committed amount
$1,944,053
Grant topic
Discovery and Translational Sciences
Duration (months)
51
Grantee location
Seattle, Washington, United States
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.